Letrasan

7,609

Product Type Product Size
Tablet 30’S
Product Company
Manufacture Deva Holding / Marketed by Searle

Letrozole 2.5mg

Category:

Description

Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon.

Reviews

There are no reviews yet.

Be the first to review “Letrasan”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsLetrasan removeHydro Urea removeSoranix removeTrexol removeTecentriq removeSedol remove
NameLetrasan removeHydro Urea removeSoranix removeTrexol removeTecentriq removeSedol remove
Image
SKU
Rating
Price7,6091,45016,710255408,260550
Stock
Availability
Add to cart

Description
Product Type Product Size
Tablet 30'S
Product Company
Manufacture Deva Holding / Marketed by Searle
Letrozole 2.5mg
Product Type Product Size
Capsules 100'S
Product Company
Pharmedic
Hydroxyurea 500mg
Product Type Product Size
Tablets 30'S
Product Company
Beacon Pharmaceuticals
Sorafenib 200mg
Product Type Product Size
Injection 1'S
Product Company
Helix pharma
Methotrexate 50mg/2ml
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Atezolizumab 1200mg/20ml
Product Type Product Size
Injection 1'S
Product Company
Helix pharma
100mg/5ml
ContentLetrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon.Hydroxyurea is in a class of medications called antimetabolites. Hydroxyurea treats cancer by slowing or stopping the growth of cancer cells in your body. Hydroxyurea treats sickle cell anemia by helping to prevent formation of sickle-shaped red blood cells.Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent. Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. " Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma.Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors.
WeightN/AN/AN/AN/AN/AN/A
DimensionsN/AN/AN/AN/AN/AN/A
Additional information